Two medical-device makers you’ve probably never heard of are in talks to merge for a price that rivals the size of small economies like Latvia, Jordan and Luxembourg.
The two companies, Medtronic and Covidien—who might as well be Transformers for all most people know—are poised to announce a $40 billion deal on Monday, unnamed sources told the Wall Street Journal.
Medtronic makes cardiovascular and orthopedic devices and is based in Minneapolis, while Covidien, which is based in Ireland, makes staplers, feeding pumps and other devices used in surgery.
The deal would lower Medtronic’s tax rate in the United States by coupling it with the lower-taxed Irish company. The U.S. corporate tax rate is 35%, and Ireland’s is 12.5%.
Huge medical company deals are apparently the mergers de nos jours, with Pfizer most recently launching an abortive takeover bid of the U.K.’s AstraZeneca, a roughly $120 billion deal.
According to the International Monetary Fund figures, Latvia’s total gross domestic product in 2013 was $38.9 billion, while Jordan’s was $40 billion and Luxembourg was $42 billion.
[WSJ]
More Must-Reads From TIME
- Jane Fonda Champions Climate Action for Every Generation
- Biden’s Campaign Is In Trouble. Will the Turnaround Plan Work?
- Why We're Spending So Much Money Now
- The Financial Influencers Women Actually Want to Listen To
- Breaker Sunny Choi Is Heading to Paris
- Why TV Can’t Stop Making Silly Shows About Lady Journalists
- The Case for Wearing Shoes in the House
- Want Weekly Recs on What to Watch, Read, and More? Sign Up for Worth Your Time
Contact us at letters@time.com